The organization has a vision to provide relief from the scourge of disease at an affordable price to the widest possible cross-section of patients. With this in view the organization has identified the therapy gaps and bridged it with unique formulations fitting squarely into the gaps. 

In the organization quality systems are well defined processes. Any aberration is mapped against the correct process to check for non compliance. If processes are inadequate, they are rejiggered and standards are reset. Gap Analysis, taking into accounts both internal & external context of competitive environment, forms the basis of strategizing for the future. Business excellence is achieved through leadership in Customer Focus & Satisfaction, Strategic Planning, Process Management & Information Analysis. Excellent quality evolves from well-designed and well executed systems & processes. This has always been a beckon light paradigm for the company.

The company today is aiming at 200 million sales in current financial year and in the coming two years’ time to achieve 500 million sales, with its operations spread all over the country with 250 people in the field, which will increase to 400 by 2006. With a well researched portfolio of ‘high yield’ and ‘high potential’ products that are in growth phase in the industry. Today the company is into the therapeutic segments of Surgery, Neurology, Gynaecology, Medicine, Dental & ENT, with anti-inflammatory antibiotics, hormone, anti-anemic and neuro tonics.
Emphasis is on high investment in field force training and marketing programmes with the objectives of building brands and creating strong presence in the market.

The organization helps employees to understand that they have to contribute and helps them do that. Emphasis on personal growth and development is a way to influence employee motivation, not only to maximize their contribution but also thereby to improve the productivity of the company.

J.S. CHAUHAN
.